Tag: Asia Pacific
Oracle Wins the Asia Pacific Biopharma Excellence Awards
Oracle Life Sciences has been felicitated with a couple of top honors at the 2025 Asia Pacific Biopharma Excellence Awards – ABEA. It is...
Advancing Asia-Pacific Healthcare & Biopharma Innovation
In order to improve healthcare and hasten drug research in their home markets, some Asian-Pacific municipal governments have established sensible policies and laws within...
Global Biopharma Market to Hit $566B by 2032
Global Biopharma Market Forecasts $566B By 2032 opposing Challenges
With a compound annual growth rate of almost 8%, from $263 billion in 2022 to $566...
The Great Hall of China: double digit growth at CPhI China
CPhI and P-MEC China , UBM Sinoexpo,CCCMHPIE,Chinese pharmaceutical market development,Asia’s largest pharma event
CPhI and P-MEC China, organised by UBM EMEA, UBM Sinoexpo and China...
Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial Giant Cell Tumor
Daiichi Sankyo Company, Limited announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of pexidartinib met its primary endpoint of tumor response as...
Popular